Page last updated: 2024-08-23

amikacin and Chemotherapy-Induced Febrile Neutropenia

amikacin has been researched along with Chemotherapy-Induced Febrile Neutropenia in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Huh, HJ; Kang, JM; Kim, YJ; Koo, HH; Lee, JW; Lee, NH; Lee, NY; Sung, KW; Yoo, KH1
Cyriac, SL; Dubashi, B; Harish, BH; Jadhav, N; Jaffa, E; Kayal, S; Matta, KK; Pattnaik, J; Pillai, US; Ponraj, M; Prakash, B; Ranjith, K; Singh, J1
Ali, N; Baqir, M; Hamid, A; Khurshid, M1
Miyamura, K; Mori, K; Mukoyama, N; Nakashima, M; Noda, Y; Yoshimi, A1

Trials

2 trial(s) available for amikacin and Chemotherapy-Induced Febrile Neutropenia

ArticleYear
Cefepime vs. cefoperazone/sulbactam in combination with amikacin as empirical antibiotic therapy in febrile neutropenia.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2018, Volume: 26, Issue:11

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Cefepime; Cefoperazone; Cephalosporins; Chemotherapy-Induced Febrile Neutropenia; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neoplasms; Sulbactam; Survival Analysis; Withholding Treatment; Young Adult

2018
Febrile neutropenia: median door-to-needle time - results of an initial audit.
    Hematology (Amsterdam, Netherlands), 2015, Volume: 20, Issue:1

    Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Chemotherapy-Induced Febrile Neutropenia; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Young Adult

2015

Other Studies

2 other study(ies) available for amikacin and Chemotherapy-Induced Febrile Neutropenia

ArticleYear
Cefepime Versus Cefepime Plus Amikacin as an Initial Antibiotic Choice for Pediatric Cancer Patients With Febrile Neutropenia in an Era of Increasing Cefepime Resistance.
    The Pediatric infectious disease journal, 2020, Volume: 39, Issue:10

    Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacteremia; Cefepime; Chemotherapy-Induced Febrile Neutropenia; Child; Child, Preschool; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant; Male; Neoplasms; Retrospective Studies; Treatment Outcome

2020
Retrospective survey and evaluation of first-line antibiotics for chemotherapy-induced febrile neutropenia in patients with acute myeloid leukemia.
    Nagoya journal of medical science, 2017, Volume: 79, Issue:1

    Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Antifungal Agents; Cefepime; Cefozopran; Cephalosporins; Chemotherapy-Induced Febrile Neutropenia; Female; Humans; Male; Middle Aged; Piperacillin; Retrospective Studies

2017